A smart inhaler is a medical device that integrates connectivity with a mobile app, via Bluetooth, for instance. These devices are built with sensor technology that helps record data about the time and date of use, and the location of the patient at each use.  

Market Dynamics:

Rise in prevalence of respiratory disorders, growing geriatric (aging) population around the world, the outbreak of COVID-19 across the globe, and increasing demand/adoption of smart inhalers are major factors expected to drive growth of the global smart inhalers market. For instance, In January 2023, Aseptika won an Innovate UK Smart Award to develop a Smart Inhaler Tracker for patients with lung health conditions. The Smart Award will help the company develop its third-generation smart inhaler tracker, which will have 5G mobile connectivity built-in. This means that patients will no longer have to send their data via a smartphone to their clinical teams, carers, or parent; it will just send information over the airwaves directly to the company’s cloud databases.

Key features of the study:

• This report provides in-depth analysis of the global smart inhalers market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global smart inhalers market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Adherium Limited, AstraZeneca, Boehringer Ingelheim, Cohero Health, GSK, Novartis, and ResMed, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global smart inhalers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smart inhalers market.

Detailed Segmentation:

• Global Smart Inhalers Market, By Product:
  • Inhalers
  • Metered Dosage Inhalers (MDIs)
  • Dry Powder Inhalers (DPIs)
  • Nebulizers
• Global Smart Inhalers Market, By Distribution Channel:
  • Hospitals
  • Pharmacies
• Global Smart Inhalers Market, By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
  • Adherium Limited
  • AstraZeneca
  • Boehringer Ingelheim
  • Cohero Health
  • GSK
  • Novartis
  • ResMed